Julia Maria Ressler (J M Ressler, Julia M Ressler, J Ressler)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Rheumatoid Arthritis

End Stage Renal Disease

Basal Cell Carcinoma

Top Venues

Dermatology and therapy

Life science alliance

Journal of cutaneous pathology

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Julia Tittes, Jennifer Brell, Pia Fritz, Constanze Jonak, Georg Stary, Julia Maria Ressler, Sarojinidevi Künig, Wolfgang Weninger, Johannes Stöckl
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα. Dermatology and therapy 14 (3) (2024)
Julia Tittes, Jennifer Brell, Pia Fritz, Constanze Jonak, Georg Stary, Julia Maria Ressler, Sarojinidevi Künig, Wolfgang Weninger, Johannes Stöckl
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα. Dermatology and therapy 14 (3) (2024)
Sophie Bromberger, Yuliia Zadorozhna, Julia Maria Ressler, Silvio Holzner, Arkadiusz Nawrocki, Nina Zila, Alexander Springer, Martin Røssel Larsen, Klaudia Schossleitner
Off-targets of BRAF inhibitors disrupt endothelial signaling and vascular barrier function. Life science alliance 7 (8) (2024)
Sophie Bromberger, Yuliia Zadorozhna, Julia Maria Ressler, Silvio Holzner, Arkadiusz Nawrocki, Nina Zila, Alexander Springer, Martin Røssel Larsen, Klaudia Schossleitner
Off-targets of BRAF inhibitors disrupt endothelial signaling and vascular barrier function. Life science alliance 7 (8) (2024)
Julia Tittes, Jennifer Brell, Pia Fritz, Constanze Jonak, Georg Stary, Julia Maria Ressler, Sarojinidevi Künig, Wolfgang Weninger, Johannes Stöckl
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα. Dermatology and therapy 14 (3) (2024)
Julia Tittes, Jennifer Brell, Pia Fritz, Constanze Jonak, Georg Stary, Julia Maria Ressler, Sarojinidevi Künig, Wolfgang Weninger, Johannes Stöckl
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα. Dermatology and therapy 14 (3) (2024)
Sophie Bromberger, Yuliia Zadorozhna, Julia Maria Ressler, Silvio Holzner, Arkadiusz Nawrocki, Nina Zila, Alexander Springer, Martin Røssel Larsen, Klaudia Schossleitner
Off-targets of BRAF inhibitors disrupt endothelial signaling and vascular barrier function. Life science alliance 7 (8) (2024)
Julia Tittes, Jennifer Brell, Pia Fritz, Constanze Jonak, Georg Stary, Julia Maria Ressler, Sarojinidevi Künig, Wolfgang Weninger, Johannes Stöckl
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα. Dermatology and therapy 14 (3) (2024)
Sophie Bromberger, Yuliia Zadorozhna, Julia Maria Ressler, Silvio Holzner, Arkadiusz Nawrocki, Nina Zila, Alexander Springer, Martin Røssel Larsen, Klaudia Schossleitner
Off-targets of BRAF inhibitors disrupt endothelial signaling and vascular barrier function. Life science alliance 7 (8) (2024)
Julia Tittes, Jennifer Brell, Pia Fritz, Constanze Jonak, Georg Stary, Julia Maria Ressler, Sarojinidevi Künig, Wolfgang Weninger, Johannes Stöckl
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα. Dermatology and therapy (2024)
Jean-Matthieu L'Orphelin, J Cassecuel, L Kandolf, C A Harwood, P Tookey, Muhammad Hyder Junejo, Sarah Hogan, C Lebbé, Zoi Apalla, T-M Kränke, Giovanni Pellacani, D Cerasuolo, Branko Dujovic, V Del Marmol, A Forschner, Claus Garbe, V Bataille, Julia Maria Ressler, P Sollena, A Dompmartin, Ketty Peris, Brigitte Dreno, null null
Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients - The European MelSkinTox study. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Julia Maria Ressler, Nina Zila, Ana Korosec, Josef Yu, Rita Silmbrod, Victoria Bachmayr, Julia Tittes, Johanna Strobl, Beate Maria Lichtenberger, Christoph Hoeller, Peter Petzelbauer
Myofibroblast stroma differentiation in infiltrative basal cell carcinoma is accompanied by regulatory T-cells. Journal of cutaneous pathology (2022)
Julia Maria Ressler, Nina Zila, Ana Korosec, Josef Yu, Rita Silmbrod, Victoria Bachmayr, Julia Tittes, Johanna Strobl, Beate Maria Lichtenberger, Christoph Hoeller, Peter Petzelbauer
Myofibroblast stroma differentiation in infiltrative basal cell carcinoma is accompanied by regulatory T-cells. Journal of cutaneous pathology (2022)
K Schumann, C Mauch, K C Klespe, C Loquai, U Nikfarjam, M Schlaak, L Akcetin, P Kölblinger, M Hoellwerth, M Meissner, G Mengi, A D Braun, M Mengoni, Reinhard Dummer, J Mangana, M A Sindrilaru, D Radmann, C Hafner, J Freund, K Rappersberger, F Weihsengruber, F Meiss, Lydia Reinhardt, F Meier, B Rainer, E Richtig, Julia Maria Ressler, C Höller, T Eigentler, Teresa Amaral, W K Peitsch, U Hillen, W Harth, F Ziller, K Schatton, T Gambichler, L Susok, L V Maul, H Läubli, D Debus, C Weishaupt, S Börger, K Sievers, S Haferkamp, V Zenderowski, V A Nguyen, M Wanner, R Gutzmer, P Terheyden, K Kähler, S Emmert, Alexander Thiem, M Sachse, S Gercken-Riedel, K M Kaune, K M Thoms, L Heinzerling, Markus Vincent Heppt, S Tratzmiller, Wolfram Hoetzenecker, A Öllinger, A Steiner, T Peinhaupt, M Podda, S Schmid, Uwe Wollina, T Biedermann, Christian Posch
Real world outcomes using PD-1 antibodies and BRAF+MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Julia Maria Ressler, Matthias Karasek, Lukas Koch, Rita Silmbrod, Joanna Mangana, Sofiya Latifyan, Veronica Aedo-Lopez, Helmut Kehrer, Felix Weihsengruber, Peter Koelblinger, Christian Posch, Julian Kofler, Olivier Michielin, Erika Richtig, Christine Hafner, Christoph Hoeller
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany. Journal for immunotherapy of cancer 9 (2) (2022)
Julia Maria Ressler, R Silmbrod, A Stepan, F Tuchmann, A Cicha, K Uyanik-Ünal, C Hoeller
Talimogene laherparepvec (T-VEC) in advanced melanoma: complete response in a heart and kidney transplant patient. A case report. The British journal of dermatology 181 (1) (2019)